Results for tag: "Idursulfase"

Idursulfase is a drug used to treat Hunter Syndrome, a rare genetic disorder that affects the body's ability to break down certain complex sugars. It is a type of enzyme replacement therapy, which works by replacing the missing enzyme in the body. Idursulfase is used to treat the symptoms of Hunter Syndrome, including joint stiffness, enlarged organs, and cognitive and behavioral problems. It is also used to slow the progression of the disease. Idursulfase is part of the Endocrine and Metabolic Disorders Drugs market, which includes drugs used to treat a variety of conditions, such as diabetes, obesity, and thyroid disorders. These drugs are used to manage symptoms, reduce the risk of complications, and improve quality of life. Companies in the Idursulfase market include Shire, Sanofi, and Genzyme. Shire is the manufacturer of Elaprase, the only FDA-approved idursulfase product. Sanofi manufactures Aldurazyme, a similar product. Genzyme produces Myozyme, a recombinant form of idursulfase. Show Less Read more